The top 100 stock
market authors
selected for publication
market authors
selected for publication
BioMarin Pharmaceutical Inc. (BMRN) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on BioMarin Pharmaceutical Inc. (BMRN) by latest | most commented
- Passport Capital Chooses Gold over Education
- Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
- Monday Options Recap
- Monday Options Update: NVAX, BMRN, TIVO & OI
- Does More Cash and Less Debt Equal Stock Market Gains?
- Biotech M&A Action: We've Only Just Begun
- Where Might Genentech Investors Redeploy $47B?
- Big Mergers Could Mean Sweet Gains for Biotech
- La Jolla Drug Failure Leaves Few Options
- Bullish Thesis for Biotech Remains Intact
- Looking for the Biotech Breakout
- SAC Capital Portfolio Update: 37 13G Filings
- Hedge Fund Portfolio Tracking: Citadel Investment Group (Ken Griffin), Q3 2008
- BioMarin Rolls the Dice on a New Lupus Drug
- New Emerging Biotech and Pharma Company Index
- Four Biotechs at Attractive Entry Points
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- Friday Options Update: MS, XLF, GFG, MTB, XLB, BMRN, IWM
- Biotech Outlook: M&A Will Continue
- Biotech Buying Binge About to Begin?
- Big Biotech Booms But IBB Falls Flat
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- Biotech Sector Continues to Outperform
- Five Biotech Stocks to Weather a Down Market
- Smallcap BioMarin's Drug Kuvan Showing Great Promise
- Gold's Just Getting Started - Barron's Interview
- Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
- Look Who's Buying Shares of BioMarin Pharmaceutical
- Biotech Day in Review: Shire Buys New River for $2.6 Billion
- Biotech Stocks Day-in-Review: BioCryst Begins Pivotal Trial of Fodosine
- Biotech Stocks Day-in-Review: Controversy For Genentech Cancer Drug
- BioMarin Recieves Approval for Aldurazyme in Japan
- Chart: Biotech Stocks - Annual Earnings Growth
- Chart: Biotech Stocks - Quarterly Earnings Growth
- Analyst Upgrades & Downgrades for Wednesday, July 19, 2006
- Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
- Chart: Biotech Stocks - Quarterly Revenue Growth
- Chart: Biotech Stocks - Change in Cash-On-Hand
- Chart: Biotech Stocks - Normalized Net Income Per Employee
- Chart: Biotech Stocks - Revenue Per Employee
- Chart: Biotech Stocks - Normalized Net Profit Margins
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Philip Davis
-
3
Tyler Durden
-
4
Bill Gross
-
5
Peter Schiff
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
